Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions
US11814383B2 · kind B2 · utility
2Cited by
7References
26Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 11, 2022 |
| Grant date | Nov 14, 2023 |
| Priority date | — |
| Expiry date | Nov 11, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, methods of inhibiting tropomyosin-related kinase and/or c-FMS, and methods of treating medical diseases and conditions, such as pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.